Otonomy, Inc. announced the appointment of Jill Broadfoot to its board of directors. Since 2018, Ms. Broadfoot has served as chief financial officer (CFO) of aTyr Pharma, Inc. Prior to joining aTyr, Ms. Broadfoot served as CFO of Emerald Health Pharmaceuticals Inc. and Emerald Health Bioceuticals Inc. where she was responsible for establishing operations for the U.S.-based pharmaceutical and bioceuticals entities. Previously, she served as Vice President, U.S. Corporate Controller at GW Pharmaceuticals, CFO of Vical Inc. and held various financial positions at DJO Global.